
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
How the supplement industry is bridging Ozempic’s nutrition gaps
The rise of GLP-1 receptor agonists such as semaglutide has thinned the waistlines of millions and opened the door for innovation in the US$200 billion supplement and nutraceutical industry. As the accessibility of drugs like Ozempic and Wegovy increases, users are eating less and discovering the biological effects of rapid weight loss.This Technical Paper is brought to you by Arjuna Natural.
Professor Gunter Eckert at the German University of Giessen explores the grey zone between food and pharmaceuticals and the regulatory challenges of communicating nutrition science. He says there is strong evidence for the Mediterranean diet’s benefits in supporting mitochondrial health and reducing the risk of neurodegeneration. Eckert discusses emerging tools to assess mitochondrial function at the individual level, highlighting the potential of personalized nutrition, while stressing that preventive strategies should prioritize diet and lifestyle.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Women's health redefined Feb 2026

GLP-1 weight management trendsFeb 2026
Multimedia
Professor Gunter Eckert at the German University of Giessen explores the grey zone between food and pharmaceuticals and the regulatory challenges of communicating nutrition science. He says there is strong evidence for the Mediterranean diet’s benefits in supporting mitochondrial health and...





























